The Anthropic IPO first day is the first trading session of ANT, Anthropic's Class A common stock, which was scheduled to begin trading on the Nasdaq Global Select Market on November 19, 2026 after pricing at $83.00 per share. As of November 19, 2026, the primary sources checked state the schedule and terms, not how ANT opened, traded or closed.
Last updated: November 19, 2026
Key Takeaways
- Anthropic priced its IPO at $83.00 per share on November 18, 2026 and said ANT was expected to begin trading on Nasdaq on November 19, 2026.
- The offering was expected to close on November 20, 2026, subject to customary conditions.
- No primary source fetched for this article states how ANT opened, traded or closed, so this page makes no such claim.
- Tradr's ANTT fund page lists November 23, 2026 as its expected first trading date.
| Item | What the primary source states | Source and date |
|---|---|---|
| Offering price | $83.00 per share | Anthropic release, November 18, 2026 |
| Shares offered | 980,000,000 Class A shares, 956,351,354 from Anthropic and 23,648,646 from selling stockholders | Anthropic release, November 18, 2026 |
| Listing | Nasdaq Global Select Market, ticker ANT, expected to begin trading November 19, 2026 | Anthropic release, November 18, 2026 |
| Closing | Expected November 20, 2026, subject to customary conditions | Anthropic release, November 18, 2026 |
| Underwriter option | 30 days, up to 147,000,000 additional shares | Anthropic release, November 18, 2026 |
| Opening, high, low and closing trades | Not shown in any source checked | Not applicable |
What Was Scheduled for the First Day?
Anthropic's November 18, 2026 release says the IPO priced at $83.00 per share and that the registration statement was declared effective by the SEC that day. The Class A common stock was expected to begin trading on the Nasdaq Global Select Market on November 19, 2026 under the symbol ANT. The offering was expected to close on November 20, 2026, subject to customary closing conditions.
The release uses the word "expected" for both dates. A schedule is not a record of what happened. For the full run of dates, see the Anthropic IPO timeline and the Anthropic IPO date guide.
What Do Primary Sources Show as of November 19, 2026?
They show the terms. Anthropic's pricing release gives the price, the share counts, the listing venue and the expected dates. The SEC submissions feed for Anthropic, fetched on November 19, 2026, listed the registration filings from November 12 to 18, 2026 and did not list a final prospectus (Form 424B4).
The Nasdaq page for ANT was reachable, but the text fetched for this article held no trading facts, because the page loads its quote data with scripts. No fetched source stated an opening price, a trade, a high, a low or a close. This page does not fill that gap with a figure. It does not state how ANT opened, traded or closed.
How Did the Final Terms Compare With the Roadshow?
Anthropic's roadshow release on November 10, 2026 proposed 825,000,000 shares at an expected range of $70.00 to $78.00, with an option for 123,750,000 more. The pricing release set 980,000,000 shares at $83.00, with an option for up to 147,000,000. Both are documented facts about the offering terms. Neither says anything about trading.
Where Can You Check Real Trading Data?
Trade prices, volume and the opening print come from the exchange and from brokerage platforms, not from the offering documents. A general explanation of how first sessions work, including why the opening trade can differ from the offering price, is in IPO first-day trading. The final prospectus, when filed, will fix the offering terms but will not report the session.
How Do the ANTT and ANTZ Funds Fit In?
Tradr ETFs lists ANTT as the 2X Long Anthropic Daily ETF and ANTZ as the 2X Short fund. ANTT's page shows a 200% daily target and a 1.49% expense ratio, and says it was expected to begin trading on November 23, 2026, the second trading day after Anthropic's IPO. ANTZ targets -200% of ANT's daily move. Fund details are in the ANTT ETF guide.
What Are the Risks?
Leveraged and inverse ETFs such as ANTT and ANTZ reset their exposure daily, so returns over more than one day can differ sharply from 2x or -2x of ANT's move. They suit short-term use by experienced traders, and investors can lose their entire investment. Newly listed stocks can also move widely, and a scheduled event can change. Read each fund's prospectus and Anthropic's final prospectus before investing.
Frequently Asked Questions
1. What price did the Anthropic IPO set?
Anthropic said its IPO priced at $83.00 per share on November 18, 2026. The offering covers 980,000,000 Class A shares, of which Anthropic sells 956,351,354 and selling stockholders sell 23,648,646. The underwriters hold a 30-day option for up to 147,000,000 additional shares.
2. When was ANT scheduled to start trading?
Anthropic said ANT was expected to begin trading on the Nasdaq Global Select Market on November 19, 2026. The offering was expected to close on November 20, 2026, subject to customary conditions. Both dates are described as expected, so confirm them with an exchange or broker.
3. Do primary sources show how ANT opened or closed?
Not in the sources checked as of November 19, 2026. Anthropic's release states terms and schedule, and the SEC feed lists filings, not trades. This page therefore makes no claim about how ANT opened, traded or closed. Use an exchange or brokerage platform for trade data.
4. Has the final prospectus been filed?
Not in the SEC feed checked on November 19, 2026. The feed listed an S-1MEF, CERT, FWP, 8-A12B and S-1/A from November 12 to 18, 2026, and no Form 424B4. Anthropic says copies of the final prospectus may be obtained, when available, from Goldman Sachs and Morgan Stanley.
Conclusion
As of November 19, 2026, the primary sources show a price of $83.00, a scheduled Nasdaq start on November 19 and an expected close on November 20. They do not show how ANT opened, traded or closed, and this page does not claim to. Check an exchange for trade data and EDGAR for the final prospectus.
References
Keep Reading
Disclaimer: This article is for educational and informational purposes only and is not investment, legal or tax advice, or a recommendation to buy or sell any security. Leveraged and inverse ETFs are complex products intended for short-term use by experienced traders, and investors can lose their entire investment. Read a fund's prospectus before investing. WOLF Financial is a digital marketing agency, not a registered investment adviser or broker-dealer.







